Whereas JAK2 mutations mimic signaling from several cytokine receptors and lead to diverse phenotypes, MPL and CALR mutations are thought to act solely through TPO and are almost exclusively associated with ET and PMF (90, 100, 101). The gene discussed is CALR; the disease is essential thrombocythemia.